MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2
Authors
Keywords
-
Journal
Genes & Genomics
Volume 43, Issue 10, Pages 1157-1165
Publisher
Springer Science and Business Media LLC
Online
2021-06-23
DOI
10.1007/s13258-021-01117-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polycomb complex mediated epigenetic reprogramming alters TGF‐β signaling via a novel EZH2/miR‐490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas
- (2019) Omkar S. Vinchure et al. INTERNATIONAL JOURNAL OF CANCER
- EZH2 Phosphorylation Promotes Self-Renewal of Glioma Stem-Like Cells Through NF-κB Methylation
- (2019) Hailong Liu et al. Frontiers in Oncology
- MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP
- (2018) Feng Ding et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation
- (2018) Wei Zhang et al. LABORATORY INVESTIGATION
- miR-137 inhibits melanoma cell proliferation through downregulation of GLO1
- (2018) Na Lv et al. Science China-Life Sciences
- miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
- (2018) Jing Sun et al. ONCOGENE
- MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma
- (2018) Bin Huang et al. PATHOLOGY RESEARCH AND PRACTICE
- MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39
- (2018) Yang Nan et al. Human Gene Therapy Clinical Development
- Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene
- (2018) Jia Qi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer
- (2017) Huimin Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- (2017) Michael Weller et al. LANCET ONCOLOGY
- miRNA-214 Inhibits Cellular Proliferation and Migration in Glioma Cells Targeting Caspase 1 Involved in Pyroptosis
- (2017) Zhenfeng Jiang et al. ONCOLOGY RESEARCH
- Glioma epigenetics: From subclassification to novel treatment options
- (2017) Olga Gusyatiner et al. SEMINARS IN CANCER BIOLOGY
- miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3
- (2017) Ruilin Chen et al. Oncology Letters
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2
- (2015) Jie Sun et al. JOURNAL OF NEURO-ONCOLOGY
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
- (2008) Joachim Silber et al. BMC Medicine
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started